Outsourcing clinical trials has become a strategic imperative for pharmaceutical and biotech companies seeking to accelerate development, optimize resources, and ensure regulatory compliance. With dozens of CROs (Contract Research Organizations) in Europe offering overlapping services, selecting the right partner can be the difference between a streamlined clinical program and costly delays.
At Palleos, we know that not all CROs deliver the same value. That’s why we emphasize the core pillars of successful CRO collaboration: operational reliability, regulatory expertise, patient access, and therapeutic specialization. Below we outline four essential factors that should guide your CRO selection process.
Speed and predictability are often the top reasons for outsourcing clinical development. Yet missed timelines and budget overruns remain common industry pitfalls. A reliable CRO doesn’t just promise delivery — it proactively manages project risk, sets transparent milestones, and keeps all stakeholders aligned. At Palleos, we treat timeline and budget adherence as critical KPIs, ensuring that sponsors have visibility and confidence at every step of the project lifecycle.
Whether you’re submitting to the EMA, navigating EAEU frameworks, or working across borders, regulatory fluency is non-negotiable. A capable CRO must possess deep knowledge of the applicable frameworks and maintain strong regulatory operations teams in-house. Our experts at Palleos have supported hundreds of successful submissions and understand how to translate regulatory complexity into clear, compliant, and expedited pathways for sponsors.
Delayed enrollment is one of the biggest threats to clinical trial success. A CRO with access to experienced investigators and high-performing sites can drastically reduce startup times and recruitment bottlenecks. Palleos offers robust feasibility assessments, streamlined site contracting, and patient-centric engagement strategies. Whether the trial requires rapid enrollment or targets niche populations, we ensure operational readiness from day one.
Each therapeutic area presents its own scientific and logistical challenges. A CRO with specific experience in your indication brings more than operational support — it offers strategic insights that improve study design, reduce risks, and optimize endpoints. Palleos specializes in key therapeutic areas including oncology, neurology, and infectious diseases, enabling us to offer tailored guidance backed by years of hands-on experience.
Selecting the right CRO is not just about ticking boxes. It’s about choosing a partner that understands your clinical development strategy, shares your urgency, and delivers results. At Palleos, we provide full-service CRO support with a focus on collaboration, transparency, and clinical excellence. Let’s discuss how our tailored CRO services can support your next study — from feasibility to submission. Contact us at: info@palleos.com.
